SCHEMBL9780346

SCHEMBL9780346

CC(CC(=O)O)C(O)c1ccc(S)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 5/20 0.39
CYSLTR2 Q9NS75 1/20 0.38
CYSLTR1 Q9Y271 1/20 0.38
GAA P10253 2/20 0.37
ALDH1A1 P00352 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
USP5 P45974 1/20 0.35
GABBR2 O75899 4/20 0.34
GABBR1 Q9UBS5 4/20 0.34
LMNA P02545 3/20 0.34
CYP2C9 P11712 2/20 0.34
CYP3A4 P08684 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
NFKB1 P19838 1/20 0.34
DRD3 P35462 1/20 0.34
BLM P54132 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1501818 0.79 FFAR1 (0.59) FFAR1GAAALDH1A1L3MBTL1USP5
SCHEMBL9780297 0.74 ALDH1A1 (0.43) FFAR1CYSLTR2CYSLTR1GAAALDH1A1
SCHEMBL9780294 0.74 ALDH1A1 (0.43) FFAR1CYSLTR2CYSLTR1GAAALDH1A1
SCHEMBL10766420 0.74 FFAR1 (0.38) FFAR1GABBR2GABBR1CYP2C9CYP1A2
SCHEMBL9863050 0.73 CYSLTR2 (0.36) FFAR1CYSLTR2CYSLTR1GAAALDH1A1
SCHEMBL9734675 0.73 CYSLTR2 (0.41) FFAR1CYSLTR2CYSLTR1GAAALDH1A1
SCHEMBL25575108 0.73 L3MBTL1 (0.49) FFAR1GAAALDH1A1L3MBTL1GABBR2
SCHEMBL9732958 0.72 POLB (0.51) FFAR1CYSLTR2CYSLTR1GAAALDH1A1
SCHEMBL11823552 0.72 MME (0.47) FFAR1
SCHEMBL20366132 0.72 L3MBTL1 (0.61) GAAALDH1A1L3MBTL1LMNACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4990526-A Skin disorders, antiallergens, antiinflammatory agents MERCK FROSST CANADA, INC. (CA) 1991-02-05 US disclosed
EP-0219308-A2 2-Substituted quinolines MERCK FROSST CANADA INC. (CA) 1987-04-22 EP disclosed
EP-0206741-A2 Leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1986-12-30 EP disclosed